RxDoctor Payments Data

Kayla Jamieson

Family Medicine · Cape Girardeau, MONPI 1184211054

Payments from drug & device makers

$3,023in general payments, 2019–2025

Across 171 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$581
  • AstraZeneca$389
  • Lundbeck LLC$190
  • Lilly USA, LLC$72
  • Johnson & Johnson$71
  • plus $671 from 19 others

What the payments were for

  • Food & beverage$3,023100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,023 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$4,279
Medicare patients
58
Services billed
314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole34$56,406
VraylarCariprazine Hcl31$56,150
UbrelvyUbrogepant44$49,119
OzempicSemaglutide50$47,570
TrulicityDulaglutide45$43,600
Invega SustennaPaliperidone Palmitate12$42,060
JardianceEmpagliflozin57$41,378
MounjaroTirzepatide39$40,661
Breztri AerosphereBudesonide/Glycopyr/Formoterol50$32,383
EliquisApixaban46$30,088
JanuviaSitagliptin Phosphate31$24,411
VascepaIcosapent Ethyl66$23,880
Combivent RespimatIpratropium/Albuterol Sulfate40$19,443
FarxigaDapagliflozin Propanediol31$16,470
LinzessLinaclotide27$14,414

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Ubrelvy, Linzess$1,049$119,683102 claims
Lilly USA, LLCTrulicity, Mounjaro$72$84,26184 claims
Boehringer IngelheimJardiance, Combivent Respimat$14$60,82197 claims
Otsuka America Pharmaceutical, Inc.Rexulti$68$56,40634 claims
Johnson & JohnsonInvega Sustenna, Xarelto$71$49,85126 claims
AstraZenecaBreztri Aerosphere, Farxiga$389$48,85381 claims
Novo NordiskOzempic$53$47,57050 claims
PfizerEliquis$15$30,08846 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Cape Girardeau

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →